The luciferase activity of these cells in the Runx2-expressed tumor cells gradually decreased with the increased expression of E-cadherin, indicating that E-cadherin inhibited MMP13 transactivation in a dose-dependent manner in the Runx2-expressed tumor cells. Here, RUNX2 is linked to neoplasm.